์ˆ˜์—… ํ๋ฆ„์„ ๊ทธ๋Œ€๋กœ ๋‹ด์•„๋‚ด๋Š” ๊ฒƒ์ด ๋ชฉ์ ์ธ ์ •๋ฆฌ๋ณธ์ž…๋‹ˆ๋‹ค. ์š”์•ฝ ์ •๋ฆฌ๋Š” ์•Œ์•„์„œ~

Mechanisms and Morphology of Cellular Injury, Adaptation, and Death

๐Ÿšฉ Table of Contents (์ด๋™์€ ์˜ค๋ฅธ์ชฝ ํ•˜๋‹จ ๋ฐ” ์ด์šฉ)

    1. The Normal Cells
    • 1.1 Basic Features of the Normal Cell
    • 1.2 Cellular Homeostasis
    1. Cellular Injury
    • 2.1 Causes of Cell Injury
    • 2๏ธ.2 Reversible Cell Injury
    1. Cell Death
    • 3.1 Oncotic Necrosis (Cell Death by Oncosis)
    • 3.2 Apoptosis
    • 3.3 Patterns of Necrosis
      • 1๏ธโƒฃ Coagulative Necrosis
      • 2๏ธโƒฃ Caseous Necrosis
      • 3๏ธโƒฃ Liquefactive Necrosis
      • 4๏ธโƒฃ Gangrenous Necrosis
      • 5๏ธโƒฃ Fat Necrosis
    1. Cellular Responses and Long-term Consequences
    • 4.1 Cellular Adaptations to Stress
    • 4.2 Intracellular Accumulations
    • 4.3 Pathologic Calcification โ† ์š”๊ธฐ ํ•˜๋Š” ์ค‘
    • 4.4 Genetic Basis of Disease

1. The Normal Cells

๋จผ์ € ์ •์ƒ ์„ธํฌ๋ฅผ ์•Œ์•„์•ผ ํ•œ๋‹ค. ์กฐ์ง์„ ๋ณธ๋‹ค = ๊ทธ ์•ˆ์—์„œ๋„ ์„ธํฌ ํ•˜๋‚˜ํ•˜๋‚˜ ์–ด๋–ค ์ผ์ด ์ผ์–ด๋‚˜๊ณ  ์žˆ๋Š”์ง€ ๋œฏ์–ด๋ณด๋Š” ๊ฒƒ๊นŒ์ง€ ํ•ด์•ผ ํ•˜๋ฏ€๋กœ.

1.1 Basic Features of the Normal Cell

  • ํ•œ ๊ฐœ์ฒด๋Š” ์—ฌ๋Ÿฌ ๊ฐœ์˜ system์œผ๋กœ ๋‚˜๋ˆŒ ์ˆ˜ ์žˆ๊ณ , ๊ฐ system์€ ์—ฌ๋Ÿฌ ๊ฐœ์˜ organ์œผ๋กœ ๊ตฌ์„ฑ๋˜์–ด ์žˆ๋‹ค.
  • Organ์€ ๊ฒฐ๊ตญ ์„ธํฌ๋กœ ๊ตฌ์„ฑ๋˜์–ด ์žˆ์œผ๋ฏ€๋กœ, ์ •์ƒ ์„ธํฌ์˜ ๊ตฌ์กฐ๋ฅผ ์•Œ๊ณ  ์žˆ๋Š” ๊ฒƒ์€ ์ค‘์š”ํ•˜๋‹ค.
  • ์„ธํฌ๋Š” ํ•œ ์ƒ๋ช…์ฒด์˜ ๊ตฌ์กฐ์ , ๊ธฐ๋Šฅ์  ๋‹จ์œ„์ด๋‹ค.
  • ๋ชจ๋“  ์„ธํฌ๋Š” ํ•ญ์ƒ์„ฑ(Homeostasis) - ์ž๊ทน์— ๋Œ€์‘ํ•˜๋Š” ๊ธฐ์ „์„ ๊ฐ€์ง„๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ์ž๊ทน์ด ์˜ค๋ž˜ ์ง€์†๋˜๋ฉด โ€˜๋ณ‘๋ณ€โ€™ (๋น„์ •์ƒ์  ์ƒํƒœ)์ด ๋œ๋‹ค.
  • ๊ฐ ์„ธํฌ ์†Œ๊ธฐ๊ด€๋“ค์€ ํŠน์ •ํ•œ ๊ธฐ๋Šฅ์„ ์ˆ˜ํ–‰ํ•œ๋‹ค. ์„ธํฌ ์†Œ๊ธฐ๊ด€์˜ ์œ ์ „์  ๋ฌธ์ œ๋กœ ๋‚˜ํƒ€๋‚˜๋Š” ์งˆ๋ณ‘๋„ ๋งŽ์œผ๋ฏ€๋กœ ๊ฐ ์„ธํฌ์†Œ๊ธฐ๊ด€์˜ ๊ธฐ๋Šฅ์„ ์•„๋Š” ๊ฒƒ๋„ ์ค‘์š”ํ•˜๋‹ค.
The Normal Cells์„ธํฌ๋ฅผ ๊ตฌ์„ฑํ•˜๋Š” ๊ฒƒ
โœ”๏ธ ํ•ต (Nucleus)
โœ”๏ธ ์„ธํฌ์งˆ (Cytoplasm)
โœ”๏ธ ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„
โœ”๏ธ์†Œํฌ์ฒด (ER)
โœ”๏ธ ๊ณจ์ง€์ฒด (Golgi apparatus)
โœ”๏ธ Lysosome & peroxisomes
โœ”๏ธ ์„ธํฌ๋ง‰ (Plasma membrane)
์„ธํฌ ๊ตฌ์กฐ
โœ”๏ธ Nucleus
- ์œ ์ „ ์ •๋ณด๋ฅผ ๋‹ด๊ณ  ์žˆ๋Š” DNA (nucleotide) + ribosome์„ ๋งŒ๋“œ๋Š” nucleolus(์ธ)
: DNA๋Š” chromatin(์—ผ์ƒ‰์งˆ) ํ˜•ํƒœ๋กœ ํŒจํ‚น๋œ๋‹ค. (DNA + histone proteins = chromatin)
- Nuclear envelope (ํ•ต๋ง‰) : ํ•ต๋ง‰์˜ nuclear pore(ํ•ต๊ณต)์„ ํ†ตํ•ด ๋ฌผ์งˆ์„ ์„ ํƒ์ ์œผ๋กœ ๋‚ด๋ณด๋‚ธ๋‹ค.
- ๋Œ€๋ถ€๋ถ„์˜ ์ „์‚ฌ(transcription)๋Š” ํ•ต ๋‚ด์—์„œ ์ผ์–ด๋‚œ๋‹ค
+ ์ด ์ „์‚ฌ ์ธ์ž๋“ค์ด ์„ธํฌ ์ฃผ๊ธฐ ์กฐ์ ˆ(cell-cycle regulation)์—๋„ ์ค‘์š”ํ•œ ์˜ํ–ฅ์„ ๋ฏธ์นœ๋‹ค.
- ํ•ต์˜ ์†์ƒ์€ ๋น„๊ฐ€์—ญ์ ์ธ ์„ธํฌ ์†์ƒ์„ ์˜๋ฏธํ•œ๋‹ค.

โ‡’ ์ข…์–‘์˜ ์–‘์•…์„ฑ์„ ํŒ์ •ํ•  ๋•Œ ํ•ต์˜ ๋ชจ์–‘, ์ธ์˜ ํฌ๊ธฐ์™€ ๋šœ๋ ทํ•จ, ํ•ต์˜ ์—ผ์ƒ‰์„ฑ ๋“ฑ์€ ์ค‘์š”ํ•œ ๋‹จ์„œ๊ฐ€ ๋œ๋‹ค.
โœ”๏ธ Cytoplasm & Organelles
Organelles : ๊ฐ๊ฐ์˜ ๊ธฐ๋Šฅ์„ ์•Œ๊ณ  ์žˆ์–ด์•ผ.
- Mitochondria : ATP ํ•ฉ์„ฑ, apoptosis ์กฐ์ ˆ
- Endoplasmic Reticulum (ER) : RER โ†’ ๋‹จ๋ฐฑ์งˆ ํ•ฉ์„ฑ
- Golgi apparatus : ๋‹จ๋ฐฑ์งˆ ํŒจํ‚น (๋ฐ–์œผ๋กœ ์šด๋ฐ˜๋  ์ˆ˜ ์žˆ๋„๋ก)
- Lysosomes & Peroxisomes : ์ฐŒ๊บผ๊ธฐ, ๋…์†Œ ์ œ๊ฑฐ
โ†’ ์™ธ๋ถ€ ์ธ์ž๋“ค์„ ์†Œํ™”(์ œ๊ฑฐ)ํ•˜๋Š” ์—ญํ• ์ด๋ฏ€๋กœ, ์ด ๋ถ€์œ„์— ๋ฌธ์ œ๊ฐ€ ์ƒ๊ธฐ๋ฉด ์‹ ๊ฒฝ ๋ณ‘์ฆ์ด ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ๋‹ค.

* ์„ธํฌ ์†Œ๊ธฐ๊ด€ ๊ฐ๊ฐ์„ ์•Œ์•„๋ณผ ์ˆœ ์—†์–ด๋„, ์—ผ์ƒ‰์„ฑ์— ๋”ฐ๋ผ โ€˜์–ด๋–ค ์†Œ๊ธฐ๊ด€์„ ๋งŽ์ด ๊ฐ€์ง€๊ณ  ์žˆ๊ตฌ๋‚˜โ€™ ์ •๋„๋Š” ์•Œ ์ˆ˜ ์žˆ๋‹ค.
ex) ํ•ญ์ฒด๋ฅผ ๋งŒ๋“œ๋Š” plasma cell์˜ ์„ธํฌ์งˆ์—๋Š” ER์ด ๋งŽ์•„์„œ ํ˜ธ์—ผ์„ฑ(๋ณด๋ผ์ƒ‰)์„ ๋ค๋‹ค. (๋ณดํ†ต์€ ํ˜ธ์‚ฐ์„ฑ-๋ถ„ํ™์ƒ‰)
โœ”๏ธ Plasma Membrane
- ์„ธํฌ์˜ ์ธ์ง€์งˆ ์ด์ค‘์ธต์—๋Š” ์—ฌ๋Ÿฌ ๊ฐ€์ง€ proteins & glycoproteins์ด ๋ฐ•ํ˜€ ์žˆ๋‹ค. (ํ•˜๋‚˜์˜ ์„ธํฌ๊ฐ€ 100๋งŒ ๊ฐœ ์ •๋„์˜ ๋‹จ๋ฐฑ์งˆ/๋‹น๋‹จ๋ฐฑ์งˆ์„ ๊ฐ€์ง„๋‹ค.)
- ๋‹น์—ฐํžˆ ์„ธํฌ ํ‘œ๋ฉด์ ์ด ํด์ˆ˜๋ก ๋‹จ๋ฐฑ์งˆ์„ ๋งŽ์ด ๊ฐ€์ง€๋Š”๋ฐ, ์ด๋Ÿฐ ์„ธํฌ๋กœ๋Š” ๋‰ด๋Ÿฐ์ด๋‚˜ ๊ทผ์œก์„ธํฌ๊ฐ€ ๋Œ€ํ‘œ์ ์ด๋‹ค. (์ˆ˜์ƒ ๋Œ๊ธฐ๊ฐ€ ๊ธด ๋‰ด๋Ÿฐ์—๋Š” channel protein์ด๋‚˜ receptor๊ฐ€ ๋” ๋งŽ๋‹ค.)
- Plasma membrane์— ์กด์žฌํ•˜๋Š” ๋‹จ๋ฐฑ์งˆ๋“ค์€ marker, channel, enzymes ๋“ฑ ๊ฐ๊ฐ์˜ ๊ธฐ๋Šฅ์„ ๊ฐ€์ง„๋‹ค.


ํ•ต, ์„ธํฌ์งˆ๊ณผ ์„ธํฌ ์†Œ๊ธฐ๊ด€, ์„ธํฌ๋ง‰์— ๋Œ€ํ•œ ๋ณด์ถฉ ๊ทธ๋ฆผ ์ž๋ฃŒ.

1.2 Cellular Homeostasis

์„ธํฌ๋Š” ์—ผ์ฆ์ด๋‚˜ ์™ธ๋ถ€ ๋…ธ์ถœ ์ƒํ™ฉ์—์„œ ๊ฐ€๋งŒํžˆ ์žˆ์ง€ ์•Š๋Š”๋‹ค. ์–ด๋–ค ๋ฐ˜์‘์„ ํ• ๊นŒ?

  • Hypertrophy : ์„ธํฌ์˜ ํฌ๊ธฐ๊ฐ€ ์ปค์ง.
  • Hyperplasia : ์„ธํฌ์˜ ๊ฐœ์ˆ˜๊ฐ€ ๋งŽ์•„์ง.
  • Adaption์ด ์ง€์†๋˜์–ด injury๋ฅผ ์œ ๋ฐœํ•˜๋ฉฐ, ์†์ƒ์€ ๊ฐ€์—ญ์ ์ด๊ฑฐ๋‚˜ ๋น„๊ฐ€์—ญ์ ์ผ ์ˆ˜ ์žˆ๋‹ค.

์–ด๋А ์ •๋„ ๊ฐ€๋ฒผ์šด ์ŠคํŠธ๋ ˆ์Šค๋Š” ์›์ธ์ด ์ œ๊ฑฐ๋˜๋ฉด ์›๋ž˜๋Œ€๋กœ ๋Œ์•„๊ฐˆ ์ˆ˜ ์žˆ๋‹ค. ํ•˜์ง€๋งŒ ๊ทธ ์ˆ˜์ค€์„ ๋„˜์–ด ๋น„๊ฐ€์—ญ์ ์ธ ๋ณ€ํ™”๊ฐ€ ๋˜๋ฉด โ†’ ์งˆ๋ณ‘์˜ ๋‹จ๊ณ„๋กœ ๊ฐ„๋‹ค.


2. Cellular Injury


์„ธํฌ ์†์ƒ์˜ ์ข…๋ฅ˜์— ๋”ฐ๋ฅธ ๋ฐ˜์‘์„ ๋„์‹ํ™”ํ•œ ๊ฒƒ.

์„ธํฌ๋Š” ๊ฐ€์—ญ์  ์†์ƒ์„ ๋ฐ›์„ ์ˆ˜๋„, ๋น„๊ฐ€์—ญ์  ์†์ƒ์„ ๋ฐ›์„ ์ˆ˜๋„ ์žˆ๋‹ค.

  1. ๋น„๊ฐ€์—ญ์ ์ธ ์†์ƒ์€ necrosis ๋˜๋Š” apoptosis๋ฅผ ์œ ๋ฐœํ•œ๋‹ค.
    • necrosis : ๊ฐ‘์ž‘์Šค๋Ÿฌ์šด ์ฃฝ์Œ โ†’ ์‹ฌํ•œ ์—ผ์ฆ ๋ฐ˜์‘์„ ๋™์›ํ•œ๋‹ค. (neutrophils, macrophages ๋“ฑ)
    • apoptosis : ๊ณ„ํš๋œ ์ฃฝ์Œ โ†’ ์กฐ์šฉํžˆ ์น˜์šด๋‹ค.(DAMPs๋ฅผ ์œ ์ถœํ•˜์ง€ ์•Š์Œ)
  2. Repair mechanism์˜ ๋ฒ”์œ„๋ฅผ ๋„˜์–ด์„ค ๋•Œ
    • apoptosis : ๊ณ„ํš์ ์œผ๋กœ ์ฃฝ์ผ ์ˆ˜๋„ ์žˆ๊ณ ,
    • senescence(์„ธํฌ ๋…ธํ™”) : repair๊ฐ€ ์ผ์–ด๋‚˜์ง€ ์•Š์•„์„œ ๋…ธํ™”๋˜์–ด ๋ฒ„๋ฆฌ๊ฑฐ๋‚˜,
    • dysplasia : ์•”์ด ๋  ์ˆ˜ ์žˆ๋‹ค.

์ฆ‰ ์šฐ๋ฆฌ๋Š” ์•ž์œผ๋กœ ์ด๋ก ๊ณผ ๊ฐ๋ก ์—์„œ ์ด๋Ÿฐ ๊ฒƒ๋“ค์„ ๋ฐฐ์šด๋‹ค.

  • ์šฐ๋ฆฌ ๋ชธ์— ์ฃผ์–ด์งˆ ์ˆ˜ ์žˆ๋Š” ๋‹ค์–‘ํ•œ ์ข…๋ฅ˜์˜ ์†์ƒ
  • ๊ทธ ์†์ƒ์ด ๊ฐ€์—ญ์  ๋ณ€ํ™”๋ฅผ ์œ ๋ฐœํ•˜๋Š”์ง€, ๋น„๊ฐ€์—ญ์  ๋ณ€ํ™”๋ฅผ ์œ ๋ฐœํ•˜๋Š”์ง€
  • ๋น„๊ฐ€์—ญ์  ๋ณ€ํ™” โ‡’ ์ข…์–‘์œผ๋กœ ๊ฐˆ ๊ฒƒ์ด๋ƒ? ์—ผ์ฆ์œผ๋กœ ๊ฐˆ ๊ฒƒ์ด๋ƒ?

์˜ ์ˆœ์ฐจ์ ์ธ ํ๋ฆ„์„ ์ดํ•ดํ•ด๋‘์ž!

2.1 Causes of Cell Injury

1๏ธโƒฃ Oxygen Deprivation (ํ—ˆํ˜ˆ์„ฑ ์†์ƒ)
  • Hypoxia : ์ €์‚ฐ์†Œ ์ƒํ™ฉ (ํ˜ธํก๊ณ„, ๋นˆํ˜ˆ, CO ๋…์„ฑ ๋“ฑ)
  • Ischemia(ํ—ˆํ˜ˆ) : ์กฐ์ง์— ํ•„์š”ํ•œ ๋งŒํผ ํ˜ˆ์•ก์ด ๊ณต๊ธ‰๋˜์ง€ ์•Š๋Š” ๊ฒƒ(reduced blood supply) โ† hypoxia์˜ ๊ฐ€์žฅ ํ”ํ•œ ์›์ธ์ด๋‹ค.
  • ๋‡Œ, ์‹ฌ์žฅ, ์‹ ์žฅ ๋“ฑ์ด ์‚ฐ์†Œ ๋ถ€์กฑ ์ƒํ™ฉ์— ํŠนํžˆ ์ทจ์•ฝ(vulnerable)ํ•˜๋‹ค.
    • ์‹ ์žฅ์€ ๋“ค์–ด๊ฐ€๋Š” ๋™๋งฅ์ด ํ•˜๋‚˜์—ฌ์„œ, ์šฐํšŒ ๊ฒฝ๋กœ๊ฐ€ ์—†๊ธฐ ๋•Œ๋ฌธ์— ํ—ˆํ˜ˆ ์ƒํ™ฉ์—์„œ ์˜ํ–ฅ์„ ๋น ๋ฅด๊ฒŒ ๋ฐ›๋Š”๋‹ค. + ATP ์†Œ๋ชจ๊ฐ€ ๋งŽ์•„์„œ ์‚ฐ์†Œ๊ฐ€ ์กฐ๊ธˆ๋งŒ ๋ถ€์กฑํ•ด๋„ ๊ธฐ๋Šฅ์ด ๋–จ์–ด์ง„๋‹ค.
    • ์ด๋Ÿฐ ์žฅ๊ธฐ์˜ ํŠน์„ฑ์„ ์ž˜ ์ดํ•ดํ•˜๊ณ  ์žˆ์œผ๋ฉด ๋ฌธ์ œ ์ƒํ™ฉ์˜ ํ•ฉ๋‹นํ•œ ์›์ธ์„ ์ฐพ๊ธฐ ์ˆ˜์›”ํ•˜๋‹ค.
2๏ธโƒฃ Infections & Immune Causes (๊ฐ์—ผ์„ฑ ์›์ธ์ฒด)
  • ๋ชจ๋“  ์›์ธ์ฒด๊ฐ€ ์†์ƒ์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค. (๋ฐ•ํ…Œ๋ฆฌ์•„, ๋ฐ”์ด๋Ÿฌ์Šค, ๊ณฐํŒก์ด, ๊ธฐ์ƒ์ถฉ ๋“ฑ)
  • direct cytopathic effect - ์›์ธ์ฒด๊ฐ€ ๋“ค์–ด์™€์„œ ์ง์ ‘์ ์œผ๋กœ ์„ธํฌ๋ฅผ ๊ณต๊ฒฉํ•  ์ˆ˜๋„ ์žˆ๊ณ ,
  • immune response - ์—ผ์ฆ ๋ฐ˜์‘์œผ๋กœ ๋™์›๋œ ๋ฉด์—ญ ์„ธํฌ์— ์˜ํ•ด ๊ฐ„์ ‘์ ์œผ๋กœ ์†์ƒ์„ ๋ฐ›์„ ์ˆ˜๋„ ์žˆ๋‹ค.
    • Hypersensitivity : pattern recognition์„ ํ•˜๋Š” ์„ ์ฒœ ๋ฉด์—ญ ์„ธํฌ(macrophages, neutrophils ๋“ฑ)์— ์˜ํ•ด ๊ฐ„์ ‘ ์†์ƒ์„ ๋ฐ›๋Š”๋‹ค.
    • Autoimmune disease : ์ƒํ”ผ์„ธํฌ ๊ฐ„ junction ๋ถ€์œ„์— ์ž๊ฐ€๋ฉด์—ญ์งˆํ™˜์ด ์ƒ๊ธฐ๋ฉด ์‰ฝ๊ฒŒ ์ฃฝ๋Š”๋‹ค. (์ƒํ”ผ์„ธํฌ๋Š” ๋”ฐ๋‹ฅ๋”ฐ๋‹ฅ ๋ถ™์–ด์žˆ๋Š” ์„ฑ์งˆ์„ ๊ฐ€์ ธ์„œ, ์„ธํฌ์™€ ์„ธํฌ ์‚ฌ์ด ์—ฐ๊ฒฐ์ด ๋Š๊ธฐ๋ฉด ์‰ฝ๊ฒŒ ์ฃฝ๋Š”๋‹ค)
3๏ธโƒฃ Physical & Chemical Agents
  • ์•„๋ž˜์™€ ๊ฐ™์ด ๋‹ค์–‘ํ•œ ๋ฌผ๋ฆฌ&ํ™”ํ•™์  ์š”์ธ๋“ค์ด ์„ธํฌ ์†์ƒ์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค.
  • Trauma (๋ฌผ๋ฆฌ์  ์†์ƒ, ๊ตํ†ต์‚ฌ๊ณ  ๋“ฑ)
  • Temperature extremes (์˜จ๋„๊ฐ€ ๋„ˆ๋ฌด ๋–จ์–ด์ง€๊ฑฐ๋‚˜ ๋†’์•„์งˆ ๋•Œ)
  • Radiation (๋ฐฉ์‚ฌ์„ฑ ๋ฌผ์งˆ)
  • Pressure
  • Toxins
    • Heavy metals (์ค‘๊ธˆ์†)
    • Drugs (ex-ํ•ญ์•”์ œ ๋“ฑ ์•ฝ์œผ๋กœ ์“ด ๊ฒŒ ์„ธํฌ๋„ ๊ณต๊ฒฉ)
    • Pesticides (ex- DDT; <์นจ๋ฌต์˜ ๋ด„>)
    • Alcohol (์•Œ์ฝ”์˜ฌ)
4๏ธโƒฃ Nutritional & Genetic Factors (์˜์–‘ & ์œ ์ „์  ์š”์ธ)
  • ๋Œ€ํ‘œ์ ์œผ๋กœ ๋น„ํƒ€๋ฏผEยท์…€๋ ˆ๋Š„ ๊ฒฐํ•์œผ๋กœ ์ธํ•œ ๋ผ์ง€์‹ฌ๊ทผ๋ณ‘์ฆ์ด ์žˆ๋‹ค.
  • ๊ณผ์˜์–‘(overnutrition), ๋น„๋งŒ(obesity) ๋˜ํ•œ ๋‹น์—ฐํžˆ ๋Œ€์‚ฌ์„ฑ ์งˆํ™˜์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค.
  • ์œ ์ „์  ๊ฒฐํ•จ์ด ํšจ์†Œ, ์ˆ˜์šฉ์ฒด, ๊ตฌ์กฐ ๋‹จ๋ฐฑ์งˆ ๋“ฑ์„ ๋ณ€ํ™”์‹œํ‚ฌ ์ˆ˜ ์žˆ๋‹ค.
  • ์˜ˆ) Lysosomal storage diseases - lysosome์˜ ํšจ์†Œ์— ๋ฌธ์ œ๊ฐ€ ์ƒ๊ฒจ ์„ธํฌ ๋‚ด ๋ฌผ์งˆ์„ ์ •์ƒ์ ์œผ๋กœ ๋ถ„ํ•ดํ•˜์ง€ ๋ชปํ•  ๋•Œ, ํŠนํžˆ ์‹ ๊ฒฝ์ด ์˜ํ–ฅ์„ ๋งŽ์ด ๋ฐ›๋Š”๋‹ค.


์†Œ๋‡Œ์˜ purkinje cell. ์‹ ๊ฒฝ ์„ธํฌ๋Š” ๋Œ€์‚ฌ ์˜์กด์„ฑ์ด ๋†’์•„ ์˜์–‘ ๋ฌธ์ œ์— ์ทจ์•ฝํ•˜๋‹ค. ์†์ƒ์„ ๋ฐ›์•„ swelling๋œ ๊ฒƒ์„ ๊ด€์ฐฐํ•  ์ˆ˜ ์žˆ๋‹ค(ํ•˜์–€์ƒ‰ ํ…… ๋นˆ ๊ณต๊ฐ„ โ†‘).

2๏ธ.2 Reversible Cell Injury

  • ์‹ฌํ•˜์ง€ ์•Š์€ ์†์ƒ์ด๋‚˜, ๋‹จ๋ฐœ์„ฑ ์†์ƒ์—์„œ๋Š” ๋‹ค์‹œ recovery๊ฐ€ ๊ฐ€๋Šฅํ•˜๋‹ค.
  • ์„ธํฌ๊ฐ€ ์†์ƒ์„ ๋ฐ›์•˜์„ ๋•Œ, ๊ฐ€์žฅ ๊ธฐ๋ณธ์ ์œผ๋กœ ๊ด€์ฐฐ๋˜๋Š” ์†Œ๊ฒฌ์ด swelling์ด๋‹ค.
    • Swelling = hydropic change (hydropic degeneration) : ์„ธํฌ ์•ˆ์— ๋ฌผ์ด ๋งŽ์•„์ง.
      • ATP ๊ฒฐํ• โ†’ ์ด์˜จ๊ตฌ๋ฐฐ๊ฐ€ ์•ˆ ๋งž์•„ Na-K channel ์ด์ƒ โ†’ ์„ธํฌ ์•ˆ์œผ๋กœ ๋ฌผ์ด ๊ณ„์† ๋“ค์–ด์™€์„œ ์„ธํฌ์งˆ๊ณผ ๋ชจ๋“  ์„ธํฌ ์†Œ๊ธฐ๊ด€๊นŒ์ง€ ๋ถ€ํ‘ผ๋‹ค.
      • ์„ธํฌ์งˆ ์•ˆ์— ๊ณตํฌ(๋นˆ ๊ณต๊ฐ„, vacuolization)๊ฐ€ ๊ด€์ฐฐ๋œ๋‹ค.

Morphologic features

  • Acute cell swelling (hydropic change) = hallmark.
  • Plasma membrane blebs, loss of microvilli.
  • Swollen mitochondria, dilated ER, ribosome detachment.
  • Cytoplasmic vacuolization may be seen.


Pathogenesis of hydropic change. ATP deletion โ†’ Naโบ/Kโบ pump failure โ†’ Sodium and water influx โ†’ cytoplasmic and organelle swelling. ์ด์˜จ ๊ตฌ๋ฐฐ๊ฐ€ ๊นจ์ง€๋ฉฐ dysfunction์œผ๋กœ ์ด์–ด์ง„๋‹ค.

๐Ÿ”ต ์ƒํ™”ํ•™์  ํŠน์ง•
  • ATP, ์‚ฐํ™”์  ์ธ์‚ฐํ™”(oxidative phosphorylation)๊ฐ€ ๊ฐ์†Œํ•œ๋‹ค.
  • ATP๊ฐ€ ๋ถ€์กฑํ•˜๋‹ˆ๊นŒ โ†’ ๋‹จ๋ฐฑ์งˆ ํ•ฉ์„ฑ๊ณผ ์†Œํ™” ํšจ์†Œ ์ž‘์šฉ๋„ ๊ฐ์†Œํ•œ๋‹ค.
  • anaerobic glycolysis๊ฐ€ ์šฐ์„ธํ•˜๊ฒŒ ์ผ์–ด๋‚œ๋‹ค โ†’ ์ –์‚ฐ์ด ์Œ“์ธ๋‹ค โ†’ lactic acidosis.
  • ์ด์˜จ ํ•ญ์ƒ์„ฑ์ด ๋ง๊ฐ€์ง„๋‹ค.

์„ธํฌ ์†์ƒ์ด ๋‹จ๋ฐœ์„ฑ์œผ๋กœ ๋๋‚˜๋Š” ๊ฒƒ์ด ์•„๋‹ˆ๋ผ, ์ด๋ ‡๊ฒŒ ์ง€์†์ ยท์—ฐ์‡„์ ์œผ๋กœ ์‹ ์ฒด์— ๋ฌธ์ œ๋ฅผ ๊ฐ€์ ธ์˜ค๋Š” ๊ฒƒ.

๐Ÿ”ต ๊ธฐ๋Šฅ์  ๊ฒฐ๊ณผ
  • ์ด์˜จ ๊ตฌ๋ฐฐ๊ฐ€ ๋ง๊ฐ€์ง€๋ฉด โ†’ Naโบ, Caยฒโบ influx, Kโบ efflux. (์†Œ๋“, ํฌํƒ€์Š˜๋ฟ ์•„๋‹ˆ๋ผ ์นผ์Š˜๋„ ์ค‘์š”ํ•˜๋‹ค!!)
    • ์นผ์Š˜ ์นจ์ฐฉ์€ ์„ธํฌ ๊ดด์‚ฌ์˜ ์ข‹์€ ์ง€ํ‘œ๊ฐ€ ๋œ๋‹ค.
      (์›๋ž˜ ์„ธํฌ ๋ฐ–์— ์žˆ์–ด์•ผ ํ•˜๋Š” ์นผ์Š˜์ด, ์„ธํฌ๊ฐ€ degeneration๋˜๋Š” ๊ณผ์ •์—์„œ ๊ณ„์† ์„ธํฌ ์•ˆ์œผ๋กœ ์œ ์ž…๋˜๋‹ค๊ฐ€, ๊ฒฐ๊ตญ ์„ธํฌ๊ฐ€ ์ฃฝ์„ ๋•Œ ์นผ์Š˜์„ ๋ฐ–์œผ๋กœ ๋‚ด๋ฑ‰๋Š”๋‹ค. ์ฆ‰, ์„ธํฌ๊ฐ€ ์žˆ๋˜ ์ž๋ฆฌ์— ์„ธํฌ๋Š” ์ฃฝ๊ณ  ์นผ์Š˜์ด ์นจ์ฐฉ๋œ๋‹ค.)
  • ๊ทผ์œก์˜ ๊ฐ•์ง์„ฑ(contractility)๋„ ๋–จ์–ด์ง€๊ณ , ์ƒ˜์˜ ๋ถ„๋น„ ๊ธฐ๋Šฅ๋„ ๋–จ์–ด์ง„๋‹ค.

์•„๊นŒ hydropic degeneration = ballooning degeneration๋„ ๊ฐ™์€ ๋ง. ์„ธํฌ์— ๋ฌผ์ด ์ฐจ์„œ ํ’์„ ์ฒ˜๋Ÿผ ๋ถ€ํ’€์–ด ์žˆ๋‹ค๋Š” ๊ฒƒ.


Hydropic degeneration: acute cell swelling์ด ์ผ์–ด๋‚œ ์„ธํฌ์˜ ํ˜„๋ฏธ๊ฒฝ ์†Œ๊ฒฌ. (์™ผ) Ballooning degeneration = hydropic degeneration์ด๋‹ค(๋งค์šฐ ์‹ฌํ•œ ํ˜•ํƒœ). ์„ธํฌ์— ๋ฌผ์ด ์ฐจ์„œ ํ’์„ ์ฒ˜๋Ÿผ ๋ถ€ํ’€๊ณ  ์„ธํฌ์งˆ์ด ํˆฌ๋ช…ํ•ด ๋ณด์ธ๋‹ค, poxvirus ๊ฐ์—ผ์—์„œ ํ”ํžˆ ๋ณผ ์ˆ˜ ์žˆ๋‹ค. (์˜ค) ์‹คํ—˜์ ์œผ๋กœ ๋งŒ๋“ค์–ด์ง„ hepatic swelling. ์˜ค๋ฅธ์ชฝ ๋ณ€์„ฑ ๋ถ€์œ„์—” ๊ดด์‚ฌ๋œ ์„ธํฌ๋“ค์ด ๋งŽ๊ณ , ์ •์ƒ ๋ถ€์œ„์™€ ๊ดด์‚ฌ ๋ถ€์œ„ ์‚ฌ์ด์— hydropic degeneration ์ค‘์ธ ์„ธํฌ๋“ค์ด ์žˆ๋‹ค(โ†).


3. Cell Death

์„ธํฌ ์‚ฌ๋ฉธ์ด necrosis์™€ apoptosis๋กœ ๊ตฌ๋ถ„๋œ๋‹ค๋Š” ๊ฒƒ์€ ๋งŽ์ด ๋“ค์–ด๋ดค์„ ๊ฒƒ!

3.1 Oncotic Necrosis (Cell Death by Oncosis)

ํ˜•ํƒœ์  ๋ชจ์–‘์— ๋”ฐ๋ผ necrosis๋ฅผ ๋ช‡ ๊ฐ€์ง€๋กœ ๋‚˜๋ˆŒ ์ˆ˜ ์žˆ๋‹ค. ๊ทธ ์ค‘ oncotic necrosis๋Š” ๋ณ‘๋ฆฌํ•™์ ์œผ๋กœ ๊ฐ€์žฅ ํ”ํ•˜๊ฒŒ ๊ด€์ฐฐํ•  ์ˆ˜ ์žˆ๋Š” ๋ณ€ํ™”.

  • โ€œOncoโ€ = hydropic (swelling) ์ด๋ผ ์ƒ๊ฐํ•˜๋ฉด ๋œ๋‹ค.
  • Oncosis๋Š” hydropic change์—์„œ ์ •์ƒ์œผ๋กœ ๋Œ์•„์˜ค์ง€ ๋ชปํ•˜๊ณ  ๊ฒฐ๊ตญ ์ฃฝ๋Š” ๊ฒƒ(necrotic cell death with swelling).
  • ํ—ˆํ˜ˆ, ๋…์†Œ, ์‹ฌํ•œ ๊ฐ์—ผ ๋“ฑ์˜ ์ƒํ™ฉ์—์„œ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ๋‹ค.
    Swelling์˜ reversible & irreversible ๊ฒฐ๊ณผ. ์„ธํฌ๊ฐ€ ์†์ƒ์„ ๋ฐ›์•˜์„ ๋•Œ ํ•˜๋Š˜์ƒ‰ ํ™”์‚ดํ‘œ(์œ„)์ฒ˜๋Ÿผ ์ •์ƒ์œผ๋กœ ๋Œ์•„๊ฐ€์ง€ ๋ชปํ•˜๊ณ  ๋นจ๊ฐ„์ƒ‰ ํ™”์‚ดํ‘œ(์•„๋ž˜)์ฒ˜๋Ÿผ ํ„ฐ์ง€๋Š” ๊ฒƒ์ด oncotic necrosis๋‹ค.
๐Ÿ”ต Pathogenesis
  • ์ค‘์š”ํ•œ ๊ฒƒ์€ calcium influx! (์นผ์Š˜์ด ์„ธํฌ ๋‚ด๋กœ ์œ ์ž…๋˜๋ฉด์„œ ์ผ์–ด๋‚˜๋Š” ์—ฌ๋Ÿฌ ๋ณ€ํ™”๊ฐ€ ์žˆ๋‹ค. ๊ฒฐ๊ตญ ์นผ์Š˜ ๋…์„ฑ์œผ๋กœ ์ฃฝ๋Š” ์…ˆ.)
  • ์ฃฝ๊ณ  ๋‚˜๋ฉด ์„ธํฌ ์•ˆ์— ์ž”๋œฉ ๋“ค์–ด์™”๋˜ ์นผ์Š˜์ด ์œ ์ถœ๋˜๋ฉด์„œ, mineralization, calcification ๋“ฑ์ด ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ๋‹ค.
  • ๋ณ‘์ธ๋ก ์ ์œผ๋กœ ์•ž์„œ ๋ดค๋˜ ๊ณผ์ •๊ณผ ์œ ์‚ฌํ•˜๋‹ค. (Injury โ†’ degeneration โ†’ oncotic necrosis)
    : ATP ๊ฒฐํ• โ†’ ์ด์˜จ๊ตฌ๋ฐฐ ๋ง๊ฐ€์ง โ†’ ๋ฌผ์ด ๋“ค์–ด์˜ค๊ณ  โ†’ ์นผ์Š˜ ์œ ์ž… โ†’ ํšŒ๋ณต๋˜์ง€ ๋ชปํ•˜๋ฉด ์ฃฝ๋Š”๋‹ค.


์„ธํฌ ๋‚ด ์นผ์Š˜ ์œ ์ž…์— ๋”ฐ๋ฅธ ๋ณ€ํ™”๋ฅผ ๋‚˜ํƒ€๋‚ธ ๊ทธ๋ฆผ. ์ผ์ผ์ด ์•Œ ํ•„์š”๋Š” ์—†๋‹ค.

๐Ÿ”ต Morphologic Features
  • ์„ธํฌ์งˆ์˜ ๋ณ€ํ™” : ํ˜ธ์‚ฐ์„ฑ์ด ์ง„ํ•ด์ง€๊ณ , detail์ด ์‚ฌ๋ผ์ง„๋‹ค.
  • ํ•˜์ง€๋งŒ ์„ธํฌ์งˆ์˜ ๋ณ€ํ™”๋Š” ์กฐ์ง์ƒ์—์„œ ๋ณด๊ธฐ ์–ด๋ ค์šฐ๋ฏ€๋กœ, ์„ธํฌ์˜ ์ฃฝ์Œ์„ ํ™•์ธํ•  ๋•Œ๋Š” ํ•ต์˜ ๋ณ€ํ™”๋ฅผ ๊ธฐ์ค€์œผ๋กœ ์‚ผ๋Š”๋‹ค:
    • pyknosis (shrinkage, ํ•ต๋†์ถ•) - ์ž‘๊ณ  ์ง„ํ•˜๊ฒŒ ์‘์ถ•๋œ๋‹ค.
    • karyorrhexis (fragmentation, ํ•ตํŒŒ๊ดด) - ์—ฌ๋Ÿฌ ์กฐ๊ฐ์œผ๋กœ ๋ถ€์„œ์ง„๋‹ค.
    • karyolysis (fading, ํ•ต์šฉํ•ด) - ๋…น์•„ ์‚ฌ๋ผ์ง„๋‹ค.
    • ํ•ต์ด ์—†์–ด์ง„ ์„ธํฌ๋ฅผ ๋‘๊ณ  โ€œghost-likeโ€๋ผ๋Š” ํ‘œํ˜„์„ ์“ด๋‹ค.

๐Ÿ”ต Tissue-Level Changes


์กฐ์ง์ƒ์—์„œ ๋ณด์ด๋Š” ์„ธํฌ์˜ ๊ดด์‚ฌ. ์™ผ์ชฝ(B) - ์‹ ์žฅ, karyolysis๊นŒ์ง€ ๋๋‚œ ์ƒํƒœ. ๊ด€ ๊ตฌ์กฐ๋Š” ๋‚จ์•„ ์žˆ์ง€๋งŒ, ์ด๋ฏธ karyolysis๊ฐ€ ์ง„ํ–‰๋˜์–ด ํ•ต์ด ๋‹ค ์—†์–ด์กŒ๋‹ค(ghost-like). ์˜ค๋ฅธ์ชฝ์—์„œ๋Š” ์•„์ง ๊ดด์‚ฌ๊ฐ€ ์ง„ํ–‰ ์ค‘์ด๋ผ ํ•ต์ด ๊ณผ์—ผ์ƒ‰์„ฑ์„ ๋ ๋Š”(์ž‘๊ณ  ์ง„ํ•œ) ๋ถ€๋ถ„๋„ ํ™•์ธํ•  ์ˆ˜ ์žˆ๋‹ค. ์˜ค๋ฅธ์ชฝ(A) - ๋น„์žฅ, karyorrhexis๊ฐ€ ์ง„ํ–‰ ์ค‘์ธ ์ƒํƒœ. ์ ์ ์ด ํŒŒํŽธํ™”๋œ ํ•ต์„ ๊ด€์ฐฐํ•  ์ˆ˜ ์žˆ๋‹ค. ํ˜ธ์ค‘๊ตฌ, ๋Œ€์‹์„ธํฌ ๋“ฑ ์—ผ์ฆ์„ธํฌ๋„ ๋™์›๋˜์–ด ์žˆ๋‹ค. ๋น„์žฅ์— ๋ฆผํ”„๊ตฌ๋‚˜ ๋Œ€์‹์„ธํฌ๋Š” ์žˆ์„ ์ˆ˜ ์žˆ์ง€๋งŒ, ์ •์ƒ์ ์œผ๋กœ ํ˜ธ์ค‘๊ตฌ๊ฐ€ ์ด๋ ‡๊ฒŒ ๋งŽ์ด ๊ด€์ฐฐ๋˜์ง€๋Š” ์•Š๋Š”๋‹ค. ๋‹จ๊ณ„๋Š” ๋‹ค๋ฅด์ง€๋งŒ, ๋‘˜ ๋‹ค ์ด๋ฏธ ๊ดด์‚ฌ๊ฐ€ ์‹œ์ž‘๋˜์–ด ๋Œ์•„๊ฐˆ ์ˆ˜๋Š” ์—†๋Š” ๊ฒƒ์€ ๊ฐ™๋‹ค.

(์ˆ˜์—…์—์„œ๋Š” ์‚ฌ์ง„ ์„ค๋ช…๋งŒ ํ•˜์…จ๋‹ค.)

  • ์œก์•ˆ์œผ๋กœ ๋ณด๋ฉด(gross) : ์ฐฝ๋ฐฑํ•ด์ง€๊ณ (pallor), ์ž˜ ๋ถ€์„œ์ง€๋ฉฐ(friability), ์กฐ์ง์ด ๋ฌผ๋Ÿฌ์ง„๋‹ค(tissue softening).
  • ํ˜„๋ฏธ๊ฒฝ์œผ๋กœ ๋ณด๋ฉด(histology) : ์ •์ƒ ์กฐ์ง์˜ ๊ตฌ์กฐ๊ฐ€ ์†Œ์‹ค๋˜๊ณ (disrupted architecture), ์—ผ์ฆ์„ธํฌ๊ฐ€ ์นจ์œค๋œ๋‹ค(inflammatory cell infiltration).
  • ์ฃผ๋ณ€์—๋Š” ์šธํ˜ˆ(vascular congestion)๊ณผ ๋ถ€์ข…(edema)๋„ ํ”ํžˆ ๋™๋ฐ˜๋œ๋‹ค.

3.2 Apoptosis

  • Necrosis์— ์˜ํ•ด ์„ธํฌ๊ฐ€ ์ฃฝ์œผ๋ฉด ๋งˆ์ง€๋ง‰์— ์—ผ์ฆ ๋ฐ˜์‘์ด ๋™์›๋œ๋‹ค. (Neutrophils, macrophages ๋“ฑ)
    ์„ธํฌ๊ฐ€ ์†์ƒ์„ ๋ฐ›์•˜๋‹ค๋Š” ์‹ ํ˜ธ(DAMPs, Damage-Associated Molecular Patterns) ๊ฐ€ ๋…ธ์ถœ๋˜์–ด ์—ผ์ฆ์„ ๋™์›ํ•˜๋Š” ๊ฒƒ.
  • Apoptosis๋Š” ์™„์ „ํžˆ ๊ณ„ํš๋œ ์ฃฝ์Œ์œผ๋กœ, ์‹ ํ˜ธ๊ฐ€ ๋‚˜์˜ค๊ธฐ ์ „์— ๋จน์–ด์น˜์›Œ์„œ ์—ผ์ฆ ๋ฐ˜์‘์ด ๋™์›๋˜์ง€ ์•Š๋Š”๋‹ค.
  • โ‡’ ์—ผ์ฆ ๋ฐ˜์‘์˜ ์œ ๋ฌด๊ฐ€ ๊ฐ€์žฅ ํฐ ์ฐจ์ด!
NecrosisApoptosis
์—ผ์ฆ ๋ฐ˜์‘์ด ๋”ฐ๋ฅธ๋‹ค.์—ผ์ฆ ๋ฐ˜์‘ ์—†์ด ๋ฐ”๋กœ ํƒ์‹๋œ๋‹ค.
๋ณ‘๋ฆฌํ•™์  ๋ฐ˜์‘์ƒ๋ฆฌํ•™์  ๋ฐ˜์‘ (๊ณ„ํš๋œ ์ฃฝ์Œ)
* ๋ฌผ๋ก  ๋ณ‘๋ฆฌํ•™์  ์ƒํ™ฉ์—์„œ๋„ ์ผ์–ด๋‚  ์ˆ˜ ์žˆ๋‹ค.
  • ํ•ต์˜ ๋ณ€ํ™”๋Š” ์œ ์‚ฌํ•˜๋‹ค. (pyknosis - karyorrhexis - karyolysis)

๐Ÿ”ต Definition & Significance
  • Apoptosis = Programmed cell death, ๊ณ„ํš์ ์œผ๋กœ ์„ธํฌ๋ฅผ ์ฃฝ์ด๋Š” ๊ฒƒ.
  • ์ƒ๋ฆฌ์  ์—ญํ•  : ๋ชธ์˜ ๋ฐœ๋‹ฌยท์œ ์ง€์— ์ •์ƒ์ ์œผ๋กœ ํ•„์š”
    • ๋ฐฐ์•„ ๋ฐœ๋‹ฌ ๊ณผ์ •์—์„œ ์›ํ•˜์ง€ ์•Š๋Š” ์„ธํฌ๋ฅผ ์ฃฝ์ธ๋‹ค. (remove unwanted or damaged cells without inflammation)
    • ํ‰์„  ํ‡ด์ถ• - ํ‰์„ (thymus)์€ ์ดˆ๊ธฐ์— ์ค‘์š”ํ•œ ๋ฉด์—ญ ๋ฐ˜์‘์„ ํ•˜๊ณ  ์ดํ›„ ์ ์  ํ‡ด์ถ•ํ•˜๋Š”๋ฐ, ์ด๋•Œ apoptosis๊ฐ€ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•œ๋‹ค.
    • ์—ผ์ฆ ๋ฐ˜์‘ ์กฐ์ ˆ - ํ•„์š” ์—†์–ด์ง„ ๋ฉด์—ญ์„ธํฌ๋ฅผ ์ œ๊ฑฐํ•œ๋‹ค.
  • ๋ณ‘๋ฆฌ์  ์—ญํ•  : ์†์ƒ๋œ ์„ธํฌ ์ œ๊ฑฐ
    • radiation์— ์˜ํ•œ DNA damage
    • ๋ฐ”์ด๋Ÿฌ์Šค ๊ฐ์—ผ ๋“ฑ
  • Apoptosis๊ฐ€ ์ œ๋Œ€๋กœ ์ž‘๋™ํ•˜์ง€ ์•Š์œผ๋ฉด ์•”(ํ†ต์ œ ๋ถˆ๊ฐ€๋Šฅํ•œ ์ฆ์‹ ์ƒํƒœ), ์ž๊ฐ€๋ฉด์—ญ์งˆํ™˜, ํ‡ดํ–‰์„ฑ ์งˆํ™˜์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค.
๐Ÿ”ต Morphologic Features
  • (Necrosis๋Š” ์„ธํฌ์งˆ์ด ํ„ฐ์ ธ์„œ ์ฃฝ๊ณ  apoptosis๋Š” ์„ธํฌ์งˆ์ด ์ชผ๊ทธ๋ผ๋“ค์–ด์„œ ์ฃฝ๋Š”๋‹ค๊ณ ๋“ค ํ•˜์ง€๋งŒ) ์‹ค์ œ ์„ธํฌ์งˆ์˜ ๋ณ€ํ™”๋Š” ๊ทธ๋ƒฅ ๋น„์Šทํ•˜๋‹ค.
  • ์„ธํฌ๋ง‰์˜ blebbing ํ˜„์ƒ๋„ ๋˜‘๊ฐ™์ด ์ผ์–ด๋‚œ๋‹ค.
  • ํ•ต์˜ ๋ณ€ํ™”๋Š” ๊ฑฐ์˜ ๋น„์Šทํ•˜๋‹ค: pyknosis(ํ•ต๋†์ถ•), karyorrhexis(ํ•ตํŒŒ๊ดด)
  • Apoptotic bodies๊ฐ€ ํ˜•์„ฑ๋œ๋‹ค.
  • Macrophage๋‚˜ ์ฃผ๋ณ€ ์„ธํฌ์— ํƒ์‹๋˜์–ด, ์—ผ์ฆ์„ธํฌ๊ฐ€ ๋™์›๋˜์ง€ ์•Š๋Š”๋‹ค.

3.3 Patterns of Necrosis

์ฐธ๊ณ ๋กœ Apoptosis๋Š” ๊ณ„ํš์ ์œผ๋กœ ์„ธํฌ๋ฅผ ์ œ๊ฑฐํ•˜๋Š” ๊ณผ์ •์ด๊ธฐ ๋•Œ๋ฌธ์— pattern์ด๋ž„ ๊ฒŒ ํฌ๊ฒŒ ์—†๋‹ค.

1๏ธโƒฃ Coagulative Necrosis

  • ๊ฐ€์žฅ ํ”ํ•˜๊ฒŒ ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ๋Š” ํŒจํ„ด.
  • ํ•ต์€ ์—†๊ณ  ์›๋ž˜์˜ ๊ตฌ์กฐ๋งŒ ๋‚จ์•„์žˆ๋Š” ๊ฒƒ์ด ํ•ต์‹ฌ! + ์•ฝ๊ฐ„ ๋ถ„ํ™๋น›(eosinophilic)
    • ์ „ํ˜•์ ์œผ๋กœ ghost cell์„ ๊ด€์ฐฐํ•  ์ˆ˜ ์žˆ๋‹ค (= ์ด๋ฏธ ํ•ต์ด ๋‹ค ์ชผ๊ฐœ์ง€๊ณ  karyolysis ์ƒํƒœ)
  • ๊ฐ€์žฅ ํฐ ์›์ธ์€ ํ—ˆํ˜ˆ(ischemia/hypoxia) โ†’ ๊ตญ์†Œ์  ํ—ˆํ˜ˆ๋กœ ์ธํ•ด ์†์ƒ์„ ์ž˜ ๋ฐ›๋Š” ์žฅ๊ธฐ๋“ค(์‹ฌ์žฅ/์‹ ์žฅ/๋น„์žฅ)์—์„œ ์ž˜ ๊ด€์ฐฐ๋œ๋‹ค.

2๏ธโƒฃ Caseous Necrosis

  • ์œก์•ˆ์ ์œผ๋กœ ํ•˜์–€์ƒ‰ ๊ฒฐ์ ˆ๋“ค์ด ๋งŽ์ด ๋ณด์ธ๋‹ค(์šธํ‰๋ถˆํ‰) - ๋ˆ์ ๋ˆ์ , ์ฐ๋“์ฐ๋“ํ•œ ๋А๋‚Œ.
    • ๊ฒฐ์ ˆ์„ ๋ณด๋ฉด: ๊ฐ€์šด๋ฐ์— ๋งค์šฐ ์‹ฌํ•œ ๊ด‘๋ฒ”์œ„ํ•œ ๊ดด์‚ฌ + ์ฃผ๋ณ€์œผ๋กœ fibroblast ๊ฐ™์€ ์„ฌ์œ ์•„์„ธํฌ or ์—ผ์ฆ์„ธํฌ + ๊ทธ ์ฃผ๋ณ€์„ ๊ฒฐํ•ฉ์กฐ์ง(fibrosis)์ด ๋‘˜๋Ÿฌ์Œˆ.
    • ์šธํ‰๋ถˆํ‰ํ•ด ๋ณด์ด๋Š” ์ด์œ ๋Š” fibrosis์— ์˜ํ•ด ๊ฒฐ์ ˆ ์ฃผ๋ณ€ ๊ฐ€์žฅ์ž๋ฆฌ๊ฐ€ ํ‘น ๊บผ์ง€๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค.
  • ์ „ํ˜•์ ์œผ๋กœ granulomatous inflammation์„ ์ผ์œผํ‚ค๋Š” mycobacterium, ๊ณฐํŒก์ด ๊ฐ์—ผ์—์„œ ์ž˜ ๊ด€์ฐฐ๋œ๋‹ค.

3๏ธโƒฃ Liquefactive Necrosis (์•กํ™” ๊ดด์‚ฌ)

  • ํšจ์†Œ์— ์˜ํ•œ ์†Œํ™”๊ฐ€ ์šฐ์„ธํ•˜์—ฌ ์กฐ์ง์ด ์•ก์ฒด์ฒ˜๋Ÿผ ๋…น์•„๋ฒ„๋ฆฐ๋‹ค. (ํ๋ฌผํ๋ฌผํ•˜๊ฒŒ ๋งŒ์ ธ์ง„๋‹ค)
  • ํŠน์ง•์ ์œผ๋กœ ์‹ ๊ฒฝ์—์„œ ๋งŽ์ด ๊ด€์ฐฐ๋œ๋‹ค. (๋‡Œ์™€ ์ฒ™์ˆ˜๋ฅผ ๋น„๋กฏํ•œ ์ค‘์ถ” ์‹ ๊ฒฝ๊ณ„) โ†’ CNS infartion(๋‡Œ๊ฒฝ์ƒ‰)์—์„œ ์ „ํ˜•์ ์ด๋‹ค.
  • ํ˜„๋ฏธ๊ฒฝ์œผ๋กœ ๋ดค์„ ๋•Œ ๊ตฌ์กฐ ์ž์ฒด๊ฐ€ ์ „ํ˜€ ๊ด€์ฐฐ๋˜์ง€ ์•Š๊ณ  ๋นˆ ๊ณต๊ฐ„์ด ๋งŽ์ด ๋ณด์ธ๋‹ค. + ํ˜ธ์ค‘๊ตฌ๊ฐ€ ๋งŽ์ด ๋ณด์ธ๋‹ค.
  • ๊ณฐํŒก์ด, ์„ธ๊ท  ๊ฐ์—ผ์—์„œ ํ˜•์„ฑ๋˜๋Š” ๋†(pus formation)์—์„œ๋„ ์ž˜ ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ๋‹ค.

4๏ธโƒฃ Gangrenous Necrosis (๊ดด์ €, ๊ดด์ €์„ฑ ๊ดด์‚ฌ)

  • ํ˜„๋ฏธ๊ฒฝ์ƒ ๋…๋ฆฝ๋œ ๊ฐœ๋…์ด๋ผ๊ธฐ๋ณด๋‹ค๋Š” ์ž„์ƒ์  ํ‘œํ˜„์ด๋‹ค.
  • Dry form (dry gangrene) : ์‹ฌ์žฅ์—์„œ ๊ฐ€์žฅ ๋จผ ๋ถ€์œ„์—์„œ ํ—ˆํ˜ˆ๋กœ ์ธํ•ด ์ผ์–ด๋‚˜๋Š” ๊ดด์‚ฌ.
    • ์‚ฌ์ง€ ๋ง๋‹จ, ์‹ ์ฒด ๋ง๋‹จ ๋ถ€์œ„์—์„œ ๋งŽ์ด ๋ฐœ์ƒํ•œ๋‹ค(์†๊ฐ€๋ฝ, ๋ฐœ๊ฐ€๋ฝ, ๊ผฌ๋ฆฌ ๋, ๊ท€ ๋, ์ –์†Œ์˜ ์œ ๋‘ ๋“ฑ).
    • ์œก์•ˆ์ ์œผ๋กœ ๊ฒ€๊ณ , ๊ฑด์กฐํ•˜๋ฉฐ ์ญˆ๊ธ€์ญˆ๊ธ€(shriveled)ํ•˜๋‹ค.
  • Wet form (wet gangrene) : ์„ธ๊ท  ๊ฐ์—ผ์ด ๊ฐ™์ด ์ผ์–ด๋‚ฌ์„ ๋•Œ. ํŠนํžˆ ์œ ์„ ์—ผ(mastitis)์˜ ์„ธ๊ท  ๊ฐ์—ผ์ด ํŠน์ง•์ ์ด๋‹ค.
    • ์œก์•ˆ์ ์œผ๋กœ ๋ถ€์–ด์žˆ๊ณ (swollen), ์ถ•์ถ•ํ•˜๊ณ , ์•…์ทจ๊ฐ€ ๋‚˜๋ฉฐ(foul-smelling), ๊ฒ€๊ฑฐ๋‚˜ ๋…น๊ฐˆ์ƒ‰์ด๋‹ค.
  • ์‚ฌ์ง€ ํ—ˆํ˜ˆ(limb ischemia), ๋™์ƒ(frostbite), ์žฅ์—ผ์ „(severe intestinal torsion) ๋“ฑ

5๏ธโƒฃ Fat Necrosis

  • ์ง€๋ฐฉ ์กฐ์ง๋„ ๊ดด์‚ฌ๋  ์ˆ˜ ์žˆ๋‹ค (๊ฐ€์žฅ ํ”ํ•˜๊ฒŒ ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ๋‹ค!).
  • lipase๊ฐ€ ์ง€๋ฐฉ์กฐ์ง์„ ๋…น์ธ๋‹ค โ†’ (์œ ๋ฆฌ์ง€๋ฐฉ์‚ฐ(free fatty acid)์ด ์นผ์Š˜๊ณผ ๊ฒฐํ•ฉ) โ†’ soap formation (saponification, ๋น„๋ˆ„์–‘ ๊ดด์‚ฌ)
  • ์œก์•ˆ ์†Œ๊ฒฌ : ๋งˆ์น˜ ์ž๊ฐˆ์„ ๋ฟŒ๋ ค๋†“์€ ๊ฒƒ์ฒ˜๋Ÿผ ํ•˜์–—๊ณ  ๋”ฑ๋”ฑํ•œ ๊ฒฐ์ ˆ๋“ค์ด ๊ด€์ฐฐ๋œ๋‹ค.
  • ์ทŒ์žฅ์—ผ์—์„œ ๊ฐ€์žฅ ํ”ํ•˜๊ฒŒ ๊ด€์ฐฐ๋œ๋‹ค. (ํŠนํžˆ ๊ธ‰์„ฑ ์ทŒ์žฅ์—ผ์ผ ๋•Œ)
    • ์ทŒ์žฅ์— ์†Œํ™”ํšจ์†Œ๊ฐ€ ์•„์ฃผ ๋งŽ์€๋ฐ, ๋‹ค๋ฅธ ์žฅ๊ธฐ๋“ค์ฒ˜๋Ÿผ ๋ฐ”๊นฅ์ชฝ์œผ๋กœ ๊ฒฐํ•ฉ์กฐ์ง์ด ๋‘๊ป์ง€๊ฐ€ ์•Š๋‹ค.
      โ‡’ ์ทŒ์žฅ์„ธํฌ์˜ ๊ดด์‚ฌ โ†’ ๋ณต๊ฐ•๋‚ด ์œ ์ถœ โ†’ ๊ทธ ์†Œํ™”ํšจ์†Œ๋“ค์ด ์ทŒ์žฅ ๊ทผ์ฒ˜ ์ง€๋ฐฉ์กฐ์ง์„ ์‹น ๋…น์ธ๋‹ค.

ํ˜„๋ฏธ๊ฒฝ์  ์„ธ์„ธํ•œ ๊ตฌ๋ถ„๋ณด๋‹ค๋Š”, ์›์ธ์— ๋”ฐ๋ฅธ ํŒจํ„ด์„ ๊ธฐ์–ตํ•ด๋‘๋ฉด ์ข‹๋‹ค!!

Patterns์›์ธ
์‘๊ณ  ๊ดด์‚ฌ (Coagulative)ํ—ˆํ˜ˆ(ischemia)
์น˜์ฆˆ์–‘ ๊ดด์‚ฌ (Caseous)Mycobacterium, fungi ๊ฐ์—ผ
(์œก์•„์ข…์„ฑ ์—ผ์ฆ)
์•กํ™” ๊ดด์‚ฌ (Liquefactive)์‹ ๊ฒฝ๊ณ„(๋‡Œ๊ฒฝ์ƒ‰ ๋“ฑ), ์„ธ๊ท ์„ฑ/์ง„๊ท ์„ฑ ๋†์–‘
๊ดด์ €์„ฑ ๊ดด์‚ฌ (Gangrenous)dry form : ๋ง๋‹จ ๋ถ€์œ„ ํ—ˆํ˜ˆ
wet form : +์„ธ๊ท  ๊ฐ์—ผ
์ง€๋ฐฉ ๊ดด์‚ฌ (Fat Necrosis)์ง€๋ฐฉ ์กฐ์ง ๊ดด์‚ฌ (ํŠนํžˆ ๊ธ‰์„ฑ ์ทŒ์žฅ์—ผ)

4. Cellular Responses and Long-term Consequences

์„ธํฌ๋“ค์ด ์ŠคํŠธ๋ ˆ์Šค์— ์–ด๋–ป๊ฒŒ ์ ์‘ํ•  ๊ฒƒ์ด๋ƒ! ํ˜•ํƒœ๋ฅผ ๋ฐ”๊พธ๊ฑฐ๋‚˜, ๊ฐœ์ˆ˜๋ฅผ ๋Š˜๋ฆฌ๊ฑฐ๋‚˜..

4.1 Cellular Adaptations to Stress

Cellular Adaptations
Hypertrophy- ์„ธํฌ ํฌ๊ธฐ ์ฆ๊ฐ€
(์„ธํฌ์˜ ํฌ๊ธฐ๋ฅผ ๋Š˜๋ ค์„œ ์ŠคํŠธ๋ ˆ์Šค์— ๋Œ€์‘ ex. ๊ณจ๊ฒฉ๊ทผ, ์‹ฌ๊ทผ์„ธํฌ)
Hyperplasia- ์„ธํฌ ์ˆ˜ ์ฆ๊ฐ€
(์ŠคํŠธ๋ ˆ์Šค์— ๋Œ€ํ•œ ์ ์‘ or ์„ฑ์žฅ ์ž๊ทน ๊ณผ๋‹ค)
- ์„ธํฌ ๊ฐœ์ˆ˜๊ฐ€ ๋Š˜์–ด๋‚˜๋ฉด ๋‚ด๊ฐ•์€ ์ข์•„์ง„๋‹ค.
* ์ง€์†์ ์ธ ์„ธํฌ์˜ ์ฆ์‹์€ ์‹ ์ƒ๋ฌผ(neoplasia)์„ ํ˜•์„ฑํ•  ์ˆ˜ ์žˆ๋‹ค.
Atrophy- ์„ธํฌ ํฌ๊ธฐ ๋˜๋Š” ์ˆ˜ ๊ฐ์†Œ (๋ณดํ†ต ๊ฐ™์ด ์ผ์–ด๋‚จ)
Metaplasia- ์›๋ž˜ ์žˆ๋˜ ์žฅ๊ธฐ์— ์กด์žฌํ•˜์ง€ ์•Š๋Š” ์„ธํฌ๋กœ ๋ณ€ํ™”
* squamous metaplasia : ์ง€์†์ ์ธ ์ž๊ทน์œผ๋กœ ์ธํ•ด ๊ทธ๋ƒฅ ํŠผํŠผํ•œ ํŽธํ‰์„ธํฌ๋กœ ๋Œ€์ฒด๋˜์–ด ๋ฒ„๋ฆผ.
โ†’ ๋ฐฉ์–ด ๊ธฐ์ œ์ด์ง€๋งŒ, ์›๋ž˜์˜ ๊ธฐ๋Šฅ์€ ์†Œ์‹ค๋จ.
- Metaplasia๊ฐ€ ์•”์œผ๋กœ ์ง„ํ–‰๋˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ๋‹ค(์ „์•”๋ณ‘๋ณ€) - ํŠนํžˆ ์žฅ์ƒํ”ผํ™”์ƒ
Dysplasia- ์„ธํฌ์˜ ํฌ๊ธฐยท๋ชจ์–‘ยท๋ฐฐ์—ด์ด ๋น„์ •์ƒ์ ์œผ๋กœ ๋ณ€ํ•˜๋Š” ์ƒํƒœ


์œ ์„  ์กฐ์ง์œผ๋กœ ์ •๋ฆฌํ•˜๋Š” ์„ธํฌ ์ ์‘์˜ ์œ ํ˜•.

4.2 Intracellular Accumulations

์„ธํฌ ์•ˆ์— ๋ญ”๊ฐ€ ์Œ“์ด๋Š” ์ƒํ™ฉ์„ ๋ณด์ž.

  • ์ฃผ๋กœ ์ง€๋ฐฉ๊ณผ glycogen์ด ์ž˜ ์Œ“์ธ๋‹ค.
  • ํฌ๊ธฐ๊ฐ€ ํฌ๊ณ  ๊ฐ€์žฅ์ž๋ฆฌ๊ฐ€ ๋šœ๋ ทํ•œ ๊ณตํฌ๋Š” ์ง€๋ฐฉ, ํฌ๊ธฐ๊ฐ€ ์ž‘๊ณ  ๊ฐ€์žฅ์ž๋ฆฌ๊ฐ€ ๋ถˆ๊ทœ์น™ยท๋ถˆ๋ถ„๋ช…ํ•˜๋ฉด glycogen์ด๋ผ๊ณ  ์ƒ๊ฐ.
โœ”๏ธ Lipid Accumulation (Steatosis, Lipidosis)
  • ๋Œ€ํ‘œ์ ์œผ๋กœ ์ง€๋ฐฉ๊ฐ„์ด ์žˆ๋‹ค. (์ •์ƒ ๊ฐ„๋ณด๋‹ค ๋ˆ„๋ฆฌ๋ผ๋ฆฌ, ๋Œ€๋ถ€๋ถ„์˜ ๊ฐ„์„ธํฌ์— ๊ณตํฌ๊ฐ€ ํ˜•์„ฑ๋˜์–ด ์žˆ๋‹ค)
    • ์„ธํฌ ๋‚ด์˜ ์ง€๋ฐฉ ์„ฑ๋ถ„์€ ์Šฌ๋ผ์ด๋“œ๋ฅผ ๋งŒ๋“œ๋Š” ๊ณผ์ • ์ค‘์— ์”ป๊ฒจ๋‚ด๋ ค๊ฐ€๊ธฐ ๋•Œ๋ฌธ์— ๋ปฅ ๋šซ๋ฆฐ ๊ฒƒ์ฒ˜๋Ÿผ ๋ณด์ธ๋‹ค.
  • ์›์ธ : ๊ฐ„๋…์„ฑ ๋ฌผ์งˆ(์‚ฌ์—ผํ™”ํƒ„์†Œ), ํ—ˆํ˜ˆ, ๋‹น๋‡จ, ๋น„๋งŒ ๋“ฑ ๋‹ค์–‘
  • ๊ฐ„์ด ์ปค์กŒ์„ ๋•Œ ์œก์•ˆ์  ๋ณ€ํ™” : ์›๋ž˜ sharpํ•œ ๊ฐ„์˜ ๋ชจ์„œ๋ฆฌ๊ฐ€ blunt(๋ญ‰ํˆญ)ํ•ด์ง„๋‹ค.

* ํฌ๊ณ  ๊ฐ€์žฅ์ž๋ฆฌ๊ฐ€ ๋šœ๋ ทํ•œ ๊ณตํฌ๋ผ๋ฉด ์ง€๋ฐฉ, ๊ณตํฌ์˜ ํฌ๊ธฐ๊ฐ€ ์ž‘๊ณ  ๊ฐ€์žฅ์ž๋ฆฌ๊ฐ€ ๋ถˆ๋ถ„๋ช…ํ•˜๋ฉด glycogen์œผ๋กœ ๊ตฌ๋ถ„ํ•จ.

Pasted image 20250909122225.png
(์™ผ) ์ „ํ˜•์ ์ธ ์ง€๋ฐฉ๊ฐ„ - ๋ˆ„๋ฆฌ๋ผ๋ฆฌํ•˜๊ฒŒ ์ง€๋ฐฉ์ด ์Œ“์ž„, ๋Œ€๋ถ€๋ถ„์˜ ๊ฐ„์„ธํฌ์— ๊ณตํฌ ํ˜•์„ฑ / (์˜ค) ๊ณผ๋„ํ•œ gluticorticoid ์‚ฌ์šฉ์œผ๋กœ ์ธํ•ด ๊ฐ„์— glycogen (~lipid) ์นจ์ฐฉ

โœ”๏ธ Glycogen Accumulation
  • PAS ์—ผ์ƒ‰์„ ํ†ตํ•ด glycogen์„ ํŠน์ด์ ์œผ๋กœ ์—ผ์ƒ‰ํ•  ์ˆ˜ ์žˆ๋‹ค(์ง„ํ•œ ๋นจ๊ฐ„์ƒ‰).
  • ์ผ๋ฐ˜์ ์ธ H/E ์—ผ์ƒ‰์—์„œ๋Š” ๊ทธ๋ƒฅ ๊ตฌ๋ฉ์ด ๋ฝ•๋ฝ• ๋šซ๋ฆฐ ๊ฒƒ์ฒ˜๋Ÿผ ๋ณด์ธ๋‹ค. (์”ป๊ฒจ ๋‚ด๋ ค๊ฐ€์„œ ๊ณตํฌํ™”)
  • ๋‹จ, ๋ฌด์–ธ๊ฐ€ ์„ญ์ทจํ•˜๊ณ  8์‹œ๊ฐ„ ์ด๋‚ด๋ผ๋ฉด ์ด glycogen ์นจ์ฐฉ์€ ์ƒ๋ฆฌํ•™์ ์œผ๋กœ ๋ฌด์กฐ๊ฑด ๋ณด์ธ๋‹ค. ์ƒ˜ํ”Œ ์ฑ„์ทจ ์ „์— ๋งˆ์ง€๋ง‰ ์„ญ์ทจ๊ฐ€ ๋ช‡ ์‹œ๊ฐ„ ์ „์ธ์ง€๋ฅผ ๋ฐ˜๋“œ์‹œ ๊ณ ๋ ค.\


Glycogen ์นจ์ฐฉ๋œ ๊ฐ„์˜ PAS ์—ผ์ƒ‰๊ณผ H&E ์—ผ์ƒ‰ ๋น„๊ต. ์ง„ํ•œ ๋นจ๊ฐ„์ƒ‰์œผ๋กœ ์—ผ์ƒ‰๋œ ๋ชจ๋“  ์„ธํฌ์— glycogen์ด ์นจ์ฐฉ๋˜์–ด ์žˆ๋‹ค.

  • Glycogen์€ ํฌ๋„๋‹น์ด ์ €์žฅ๋˜๋Š” ํ˜•ํƒœ์ด์ง€๋งŒ ์–ด๋–ค ์ƒํ™ฉ์—์„œ๋Š” ์„ธํฌ ๋‚ด์— ๊ณผ๋„ํ•œ glycogen์ด ์ถ•์ ๋˜๊ธฐ๋„ ํ•œ๋‹ค.
    • ๊ฐ„์„ธํฌ Hepatocytes (๊ฐ€์žฅ ํ”ํ•ฉ, ๊ฐ„๋น„๋Œ€ ์œ ๋ฐœ)
    • ์‹ ์„ธ๋‡จ๊ด€ ์„ธํฌ Renal tubular cells (๋‹น๋‡จ๋ณ‘์—์„œ ํ”ํžˆ ๊ด€์ฐฐ)
    • ์ทŒ์žฅ ฮฒ์„ธํฌ
    • ์‹ฌ๊ทผ์„ธํฌ Cardiomyocytes
  • ์›์ธ : diabetes mellitus(๋‹น๋‡จ-ํ˜ˆ๋‹นโ†‘), steroid therapy(์Šคํ…Œ๋กœ์ด๋“œ ํˆฌ์—ฌ), glycogen storage diseases(์„ ์ฒœ์  ํšจ์†Œ ๊ฒฐํ•์œผ๋กœ ๋ถ„ํ•ดX)
โœ”๏ธ Protein Accumulation


Reabsorption droplets in renal tubular epithelium. ๋ถ‰๊ณ  ๋™๊ธ€๋™๊ธ€ํ•œ ๊ณผ๋ฆฝ์ด ๊ด€์ฐฐ๋œ๋‹ค -์ •์ƒ์ ์ธ ๊ณผ๋ฆฝ์„ฑ ์„ธํฌ์งˆ๊ณผ ๋‹ฌ๋ฆฌ ๊ณผ๋ฆฝ ํ•˜๋‚˜ํ•˜๋‚˜ ๊ต‰์žฅํžˆ ํฌ๊ณ  ๋šœ๋ ทํ•˜๋‹ค.

  • ์‹ ์žฅ์—์„œ ์ „ํ˜•์ ์œผ๋กœ ๋‹จ๋ฐฑ์งˆ ์นจ์ฐฉ์ด ์ž˜ ๊ด€์ฐฐ๋œ๋‹ค.

  • ๊ณผ๋„ํ•œ ๋‹จ๋ฐฑ์งˆ์„ฑ ์งˆํ™˜์ด๋‚˜ PLE(Protein-Losing Enteropathy)์—์„œ ์ด๋Ÿฐ ์†Œ๊ฒฌ์ด ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ๋‹ค.

    • PLE : ๋‹จ๋ฐฑ์งˆ์„ ์ œ๋Œ€๋กœ ํก์ˆ˜ํ•˜์ง€ ๋ชปํ•˜๊ณ  ๊ณ„์† ๋ฐฐ์ถœํ•˜๋Š” ์งˆํ™˜ โ†’ ๊ทธ๋Ÿฐ๋ฐ ์‹ ์žฅ์—์„œ ๊ณ„์† ์žฌํก์ˆ˜ํ•˜๋ ค๊ณ  ๋…ธ๋ ฅํ•˜๊ธฐ ๋•Œ๋ฌธ์— ๋‹จ๋ฐฑ์งˆ ๊ณผ๋ฆฝ์ด ์„ธ๋‡จ๊ด€ ๊ณณ๊ณณ์—์„œ ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ๋‹ค.

โœ”๏ธ Pigment Accumulation
  • ๊ฐˆ์ƒ‰ ๊ณผ๋ฆฝ์ด ๊ณณ๊ณณ์— ์กด์žฌ.

  • ์ถฉํ˜ˆ : ํ˜ˆ๊ด€ ์•ˆ์— RBC๊ฐ€ ๋งŽ์ด ์ฐจ ์žˆ๋Š” ๊ฒƒ.

  • ์ถœํ˜ˆ : ํ˜ˆ๊ด€ ๋ฐ–์œผ๋กœ RBC๊ฐ€ ๋‚˜์™€์žˆ๋Š” ๊ฒƒ.

  • ๊ฐˆ์ƒ‰ ๊ณผ๋ฆฝ : hemosiderosis

  • Hemosiderosis์— ๋”ฐ๋ผ ์ถœํ˜ˆ์ด ์žˆ์—ˆ๋Š”์ง€ ์—†์—ˆ๋Š”์ง€ ํŒ๋‹จํ•˜๋Š” ๊ธฐ์ค€์ด ๋จ.

  • ๊ฐœ๊ณ ์–‘์ด๋Š” ์„๋ฉด ๊ฐ™์€ ๊ฒƒ์— ์ˆด๊ธฐ

  • ์ƒ‰์†Œ์นจ์ฐฉ์˜ ์ƒ‰๊น”์ด๋‚˜ ํŒจํ„ด์— ๋”ฐ๋ผ ์›์ธ์„ ํŒ๋‹จ

4.3 Pathologic Calcification

Dystrophic calcification
  • ์นผ์Š˜ ์นจ์ฐฉ์€ ๋งค์šฐ ์ค‘์š”ํ•˜๋‹ค.
  • ๊ณจ์กฐ์ง์—์„œ ์œ ๋ž˜ํ•œ osteosarcoma
  • ์œก์•ˆ์ ์œผ๋กœ ํ•˜์–€ ๊ฒฐ์ ˆ ํ˜•ํƒœ๋กœ ๋ณด์ผ ์ˆ˜ ์žˆ๋‹ค โ†’ ์นผ์Š˜ ์นจ์ฐฉ์ธ์ง€, ์นผ์Š˜์ด ํ’๋ถ€ํ•œ ์กฐ์ง์ด ๋น„์ •์ƒ์ ์œผ๋กœ ์ž๋ฆฌํ•œ ๊ฒƒ์ธ์ง€ ๊ตฌ๋ถ„ํ•ด์•ผ ํ•œ๋‹ค.
  • ์„ธํฌ ์•ˆ์˜ ์นผ์Š˜์ด ์œ ์ถœ๋˜์–ด ์ž๋ฆฌํ•  ์ˆ˜๋„ ์žˆ๊ณ , ํ˜ˆ์ค‘ ์นผ์Š˜ ๋†๋„๊ฐ€ ๊ณผ๋„ํ•˜๊ฒŒ ๋†’์•„ ๋ฐฐ์ถœ๋˜์ง€ ๋ชปํ•˜๊ณ  ์ฒด๋‚ด์— ์Œ“์ด๋Š” ๊ฒฝ์šฐ๊ฐ€ ์žˆ๋‹ค. (์ž˜ ์นจ์ฐฉ๋˜๋Š” ์œ„์น˜ : )
  • ํ˜„๋ฏธ๊ฒฝ์  ์†Œ๊ฒฌ ; ํ˜ธ์—ผ์„ฑ, ๊ฑฐ์น ํ•˜๊ณ  ๊นŒ๋Œํ•œ ๋А๋‚Œ
Metastatic calcification
  • ์›๋ž˜ ์นผ์Š˜์ด ๋งŽ์ด ์กด์žฌํ•˜๋Š” ๋ถ€์œ„๊ฐ€ ์•„๋‹Œ๋ฐ ๋‹ค๋ฅธ ๋ถ€์œ„์˜ ๋†’์€ ์นผ์Š˜ ๋†๋„ ๋•Œ๋ฌธ์— ๋น„์ •์ƒ์ ์œผ๋กœ ์Œ“์ธ ๊ฒƒ
  • ๊ฐ€์žฅ ๋Œ€ํ‘œ์ ์ธ ์›์ธ์€ hypercalcemia
    • ์ด์˜ ์›์ธ์„ ๋‹ค์‹œ ํŒŒ์•…ํ•ด์•ผ ํ•œ๋‹ค : hyperparathyroidism, vitamin D toxicity, renal failure, bone destruction(๊ณจ์˜ ์žฌํก์ˆ˜๊ฐ€ ์ผ์–ด๋‚˜๋ฉด..)
  • ์นผ์Š˜์ด ์ž˜ ์นจ์ฐฉ๋˜๋Š” common sites๋Š” ์œ„์ ๋ง‰, ์‹ ์žฅ, ํ, ๋™๋งฅ ์ฃผ๋ณ€. ํ˜ˆ์ค‘ ์นผ์Š˜ ๋†๋„๊ฐ€ ๋†’์•„์ง€๋ฉด ํ˜ˆ๊ด€ ์ฃผ๋ณ€์— ํ•„์—ฐ์ ์œผ๋กœ ๋‚˜ํƒ€๋‚œ๋‹ค.
  • Microscopy : interstitial basophilic deposits (Intracellular X - ์„ธํฌ ์•ˆ์ด ์•„๋‹ˆ๋ผ ์‚ฌ์ด์‚ฌ์ด์— ์Œ“์ž„.)
Cellular Aging
  • ๊ณ ๊ณณ์— ์žฅ๊ธฐ ํŠน์ด์ ์ธ ์ค„๊ธฐ์„ธํฌ๊ฐ€ ์žˆ๋Š”๋ฐ, ๊ณ„์† ๋ถ„์—ดํ•˜์—ฌ ์ƒˆ๋กœ์šด ์„ธํฌ๋ฅผ ๋งŒ๋“ค์–ด๋ƒ„.
  • ์žฅ๊ธฐ ํŠน์ด์  ์ค„๊ธฐ์„ธํฌ์— aging์ด ์ƒ๊ธฐ๋ฉด ์„ธํฌ ์ฆ์‹๋Šฅ์ด ํ˜„์ €ํ•˜๊ฒŒ ๋–จ์–ด์ ธ, ์ƒˆ๋กœ์šด ์„ธํฌ๋ฅผ ๋งŒ๋“ค์–ด๋‚ด์ง€ ๋ชปํ•œ๋‹ค. ์žฌ์ƒ ๋Šฅ๋ ฅ์ด ๋–จ์–ด์ง€๋Š” ๊ฒƒ. ๋ˆˆ์ด ์•ˆ ๋ณด์ด๊ณ , ๊ท€๊ฐ€ ์•ˆ ๋“ค๋ฆฌ๋Š” ๋“ฑ์˜ ๋…ธํ™”๊ฐ€ ์ด๋ ‡๊ธฐ ๋•Œ๋ฌธ. DNA repair์˜ ๊ฒฐํ•จ,

4.4 Genetic Basis of Disease

1) General Concepts
  • ๋ชจ๋“  ์งˆ๋ณ‘์— ์œ ์ „ ์†Œ์ธ์ด ์žˆ๋‹ค๊ณ  ๋งํ•  ์ˆ˜ ์žˆ์„ ๋งŒํผ ์ค‘์š”ํ•˜์ง€๋งŒ, ์–ด๋–ค ํ™˜๊ฒฝ์— ๋…ธ์ถœ๋˜์–ด ์žˆ๋Š”์ง€๊ฐ€ ๋ฐœํ˜„์„ ๋งŽ์ด ๊ฒฐ์ •ํ•œ๋‹ค.
  • ํ™˜๊ฒฝ์  ์š”์ธ์ด ์œ„ํ—˜ํ•œ ์ด์œ ๋Š” ์ƒ๋ช…์ฒด์˜ DNA๋ฅผ ์†์ƒ์‹œํ‚ค๊ณ , ์ด๊ฒƒ์ด ๋ˆ„์ ๋˜์–ด mutation์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค.
  • Mutation : ๊ณ„์†๋œ inbreeding์œผ๋กœ ์ธํ•ด ์ƒ๊ธฐ๋Š” ๋ฌธ์ œ์ . ์šฐ๋ฆฌ๊ฐ€ ๋ณด๋Š” ๋งŽ์€ ๊ฐœ๋“ค์€ inbreeding์„ ๊ฑฐ์ณค๊ธฐ ๋•Œ๋ฌธ์— ํ’ˆ์ข… ํŠน์ด์  ์œ ์ „์งˆํ™˜์„ ๊ฐ€์ง„๋‹ค.
  • ์œ ์ „ ์†Œ์ธ์€ โ€˜์†Œ์ธโ€™์ผ ๋ฟ, ํ•ญ์ƒ ๊ฒฐ๊ณผ๋กœ ์ด์–ด์ง€์ง€๋Š” ์•Š๋Š”๋‹ค. ํ™˜๊ฒฝ์  ์ž๊ทน์ด๋‚˜ ์ถ”๊ฐ€ ์กฐ๊ฑด์ด ๋ฐœํ˜„ ์—ฌ๋ถ€, ๋ฐœํ˜„ ํ˜•ํƒœ์— ์˜ํ–ฅ์„ ์ค€๋‹ค.
  • inherited = ๋ถ€๋ชจ๋กœ๋ถ€ํ„ฐ ๋ฌผ๋ ค๋ฐ›์€ ์†Œ์ธ / acquired = ํ™˜๊ฒฝ์  ์š”์ธ (์ƒํ™œ ์–‘์‹ ๋“ฑ)
  • Mutation์€ 1๊ฐœ์˜ ์œ ์ „์ž, ์—ฌ๋Ÿฌ ๊ฐœ์˜ ์œ ์ „์ž, ํ˜น์€ ์—ผ์ƒ‰์ฒด ์ž์ฒด์—๋„ ์žˆ์„ ์ˆ˜ ์žˆ๋‹ค. (X-linked โ‡’ ์—ผ์ƒ‰์ฒด ์ž์ฒด์— ๋ฌธ์ œ)
  • ์œ ์ „์  ๊ฒฐํ•จ์€ ํ•ญ์ƒ ์†์ƒ์ด๋‚˜ ๊ธฐ๋Šฅ ์ด์ƒ์œผ๋กœ ๋‚˜ํƒ€๋‚˜์ง€๋Š” ์•Š๋Š”๋‹ค. (can predispose)
2) Types of genetic mutations

์–ด๋–ค mutation์ด ์–ด๋–ค ์งˆ๋ณ‘์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋Š”์ง€๋Š” ์•Œ์•„๋†”์•ผ ํ•จ. ํŠน์ • ์œ ์ „ ์†Œ์ธ๊ณผ ๊ด€๋ จ๋œ ์งˆ๋ณ‘์€ ์•Œ์•„๋‘˜ ํ•„์š”๊ฐ€ ์žˆ๋‹ค.

Point mutationssingle nucleotide changes โ†’ missense, nonsense
Insertions/deletionsframeshifts altering reading frame
Trinucleotide repeat expansionse.g., Huntingtonโ€™s, fragile X.
Chromosomal abnormalitiesdeletions, duplications, translocations

germline mutation : ํƒœ์–ด๋‚  ๋•Œ๋ถ€ํ„ฐ ์ด๋ฏธ ๋ฐ›์€ ๊ฒƒ. somatic mutation : ํƒœ์–ด๋‚œ ์ดํ›„์— ์–ป์–ด์ง„ ๊ฒƒ. ํ‘œํ˜„ํ˜• ๋ฐœํ˜„ ๋นˆ๋„์— ์ฐจ์ด๊ฐ€ ๋‚จ.

Single-Gene Disorders- Enzyme defects : lysosomal storage diseases
- Receptor๊ฐ€ ์ œ๋Œ€๋กœ ์ž‘๋™ํ•˜์ง€ ์•Š๊ฑฐ๋‚˜(receptor defects) โ†’ familial hypercholesterolemia
- ์ด์˜จ ์„ฑ๋ถ„์„ ์ฃผ๊ณ ๋ฐ›๋Š” channel์— ๋ฌธ์ œ๊ฐ€ ์ƒ๊ฒผ์„ ๋•Œ (channel defects) โ†’ ion channelopathies
Multifactorial Disorders* ์œ ์ „ ์†Œ์ธ + ํ™˜๊ฒฝ
- Hip dysplasia : ์œ ์ „ ์†Œ์ธ์ด ์žˆ์œผ๋ฉฐ, ํ™œ๋™์ ์ด๊ฑฐ๋‚˜ ๊ณจ๋ฐ˜์— ์ถฉ๊ฒฉ์ด ๋งŽ์ด ๊ฐ€๋Š” ํ™˜๊ฒฝ์— ์žˆ์œผ๋ฉด ๋†’์€ ํ™•๋ฅ ๋กœ ๋ฐœํ˜„๋จ.
- Diabetes melitus :
- Cancer predisposition : ์•”์€ ์˜ค๋žœ ์‹œ๊ฐ„์˜ ์ถ•์ ์œผ๋กœ ๋ฐœํ˜„๋จ, ํ™˜๊ฒฝ ์š”์ธ์ด ๋งŽ์€ ์˜ํ–ฅ์„ ๋ฏธ์นจ.
Chromosomal & Mitochondrial Abnormalities
Genetic Disorders by SpeciesBreeds
Dog
AmyloidosisShar-Pei, Beagle
Muscular dystrophyGolden Retriever, Irish Terrier
Copper toxicosisBedlington Terrier, Labrador Retriever
Osteogenesis imperfectaBeagle, Dachshund
Cat
Polycystic kidney diseasePersian, related breeds
Mucopolysaccharidosis VISiamese, Domestic Shorthair
GM1 gangliosidosisKorats
Hypokalemic polymyopathyBurmese
Pig
Porcine stress syndrome (malignant hyperthermia)Landrace, Pietrain
Splay legVarious breeds
Horse
Hyperkalemic periodic paralysis (HYPP)Quarter Horse
Glycogen branching enzyme deficiencyQuarter Horse, Paint Horse
Severe combined immunodeficiency (SCID)Arabian
Overo lethal white foal syndromePaint Horse
Cattle
BLAD (Bovine leukocyte adhesion deficiency)Holstein
Deficiency of uridine monophosphate synthase (DUMPS)Holstein
Complex vertebral malformation (CVM)Holstein
Bovine citrullinemiaHolstein